Rituximab improved systemic lupus erythematosus-associated pulmonary alveolar proteinosis without decreasing anti-GM-CSF antibody levels

Abstract

Get full access to this article

View all access options for this article.

References

Trapnell

Whitsett

Nakata

. Pulmonary alveolar proteinosis. N Engl J Med 2003; 349: 2527–2539.

Nagasawa

Kurasawa

Maezawa

Owada

Hanaoka

Fukuda

. Systemic lupus erythematosus complicating autoimmune pulmonary alveolar proteinosis that was worsened by immunosuppressive therapy. Lupus 2013; 22: 1060–1063.

Uchida

Beck

Yamamoto

. GM-CSF autoantibodiesand neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 2007; 356: 567–579.

Kavuru

Malur

Marshall

. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J 2011; 38: 1361–1367.